Showing Form 4 filings for CMPX
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Compass Therapeutics, Inc.
Price
$0.59
Shares
10,000
Ownership
430,000
Value/Share
Lerner Neil
CHIEF ACCOUNTING OFFICER
Unknown
Industry
CMPX
$0.92
20,000
420,000
$1.14
2,500
400,000
$1.89
25,000
196,000
Anderman Jonathan
GC
15,000
397,500
$2.11
6,480,825
Schuetz Thomas J.
CEO
$1.59
3,571,428
15,219,994
Gordon Carl L
Dir, 10%
Orbimed Advisors LLC
$1.54
21,000
GC, Corporate Sec
$1.42
320,000